Bempegaldesleukin selectively depletes intratumoral Tregs and potentiates T cell-mediated cancer therapy. - Sharma M; Khong H; Fa'ak F; Bentebibel SE; Janssen LME; Chesson BC; Creasy CA; Forget MA; Kahn LMS; Pazdrak B; Karki B; Hailemichael Y; et al. (Nature communications, 2020)